Bover J, Bailone L, López-Báez V, Benito S, Ciceri P, Galassi A, et al. Osteoporosis, bone mineral density and CKD–MBD: treatment considerations. J Nephrol. 2017;30:677–87.

Article  PubMed  Google Scholar 

Marinho BCG, Guerra LP, Drummond JB, Silva BC, Soares MMS. The burden of osteoporosis in Brazil. Arquivos Brasileiros de Endocrinol Metabol. 2014;58:434–43.

Article  Google Scholar 

Merle B, Haesebaert J, Bedouet A, Barraud L, Flori M, Schott A-M, et al. Osteoporosis prevention: Where are the barriers to improvement in French general practitioners? A qualitative study. PLoS ONE. 2019;14(7): e0219681.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mariani G, Kasznia-Brown J, Paez D, Mikhail MN, Salama DH, Bhatla N, et al. Improving women’s health in low-income and middle-income countries. Part I: challenges and priorities. Nucl Med Commun. 2017;38(12):1019.

Article  PubMed  PubMed Central  Google Scholar 

Hassan WN, Shallal F, Roomi AB. Prediction of successful Induction of labor using ultrasonic fetal parameters. Current Women’s Health Rev. 2022;18(1):134–9.

Article  Google Scholar 

Radecka A, Lubkowska A. The significance of dual-energy x-ray absorptiometry (DXA) examination in cushing’s syndrome—A systematic review. Diagnostics. 2023;13(9):1576.

Article  PubMed  PubMed Central  Google Scholar 

Kuo T-R, Chen C-H. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker Res. 2017;5(1):1–9.

Article  Google Scholar 

Marini S, Barone G, Masini A, Dallolio L, Bragonzoni L, Longobucco Y, et al. The effect of physical activity on bone biomarkers in people with osteoporosis: a systematic review. Front Endocrinol. 2020;11: 585689.

Article  Google Scholar 

Farrag M, Ait Eldjoudi D, González-Rodríguez M, Cordero-Barreal A, Ruiz-Fernández C, Capuozzo M, et al. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol. 2023;13:1101091.

Article  Google Scholar 

Hekim MG, Kelestemur MM, Bulmus FG, Bilgin B, Bulut F, Gokdere E, et al. Asprosin, a novel glucogenic adipokine: a potential therapeutic implication in diabetes mellitus. Arch Physiol Biochem. 2021;129:1–7.

Google Scholar 

Cavati G, Pirrotta F, Merlotti D, Ceccarelli E, Calabrese M, Gennari L, et al. Role of advanced glycation end-products and oxidative stress in type-2-diabetes-induced bone fragility and implications on fracture risk stratification. Antioxidants. 2023;12(4):928.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang L, Chen C, Zhou N, Fu Y, Cheng X. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta. 2019;489:183–8.

Article  CAS  PubMed  Google Scholar 

Roomi AB, Nori W, Al-Badry SH. The value of serum adiponectin in osteoporotic women: does weight have an effect? J Obesity. 2021;2021.

Al-Jawadi WA, Jankeer MH. Study of the balance system between some enzymatic and non-enzymatic antioxidants in blood serum of patients with rheumatoid arthritis in Mosul City, Iraq. Medico-Legal Update. 2021;21(1).

Fox C, Bernardino L, Cochran J, Essig M, Bridges KG. Inappropriate use of homeostasis model assessment cutoff values for diagnosing insulin resistance in pediatric studies. J Am Osteopath Assoc. 2017;117(11):689–96.

PubMed  PubMed Central  Google Scholar 

Czerwiński E, Badurski JE, Marcinowska-Suchowierska E, Osieleniec J. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. Ortop Traumatol Rehabil. 2007;9(4):337–56.

PubMed  Google Scholar 

Chow S-C, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research: CRC press; 2017.

Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, et al. The role of adipokines in health and disease. Biomedicines. 2023;11(5):1290.

Article  PubMed  PubMed Central  Google Scholar 

Morcos YA, Lütke S, Tenbieg A, Hanisch F-G, Pryymachuk G, Piekarek N, et al. Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin. Sci Rep. 2022;12(1):1340.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naiemian S, Naeemipour M, Zarei M, Lari Najafi M, Gohari A, Behroozikhah MR, et al. Serum concentration of asprosin in new-onset type 2 diabetes. Diabetol Metab Syndr. 2020;12:1–8.

Article  Google Scholar 

Groener JB, Valkanou A, Kender Z, Pfeiffenberger J, Kihm L, Fleming T, et al. Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes. PLoS ONE. 2019;14(9): e0222771.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Liao M, Shen R, Zhang L, Hu H, Wu J, et al. Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediat Inflammat. 2018;2018.

Wang C-Y, Lin T-A, Liu K-H, Liao C-H, Liu Y-Y, Wu VC-C, et al. Serum asprosin levels and bariatric surgery outcomes in obese adults. Int J Obes. 2019;43(5):1019–25.

Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, et al. Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediat Inflamm. 2018;2018.

Cantay H, Binnetoglu K, Gul HF, Bingol SA. Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy. Obesity. 2022;30(8):1639–46.

Article  CAS  PubMed  Google Scholar 

Gozel N, Kilinc F. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin. Endokrynol Pol. 2021;72(1):37–43.

Article  CAS  PubMed  Google Scholar 

Kantorowicz M, Szymura J, Szygula Z, Kusmierczyk J, Maciejczyk M, Wiecek M. Nordic walking at maximal fat oxidation intensity decreases circulating asprosin and visceral obesity in women with metabolic disorders. Front Physiol. 2021;12: 726783.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Huang X, Sun K, Li M, Wang X, Han T, et al. The potential role of serum IGF-1 and leptin as biomarkers: towards screening for and diagnosing postmenopausal osteoporosis. J Inflamm Res. 2022:533–43.

Mohsin S, Baniyas MM, AlDarmaki RS, Tekes K, Kalász H, Adeghate EA. An update on therapies for the treatment of diabetes-induced osteoporosis. Expert Opin Biol Ther. 2019;19(9):937–48.

Article  CAS  PubMed  Google Scholar 

Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: a novel player in metabolic diseases. Front Endocrinol. 2020;11:64.

Article  Google Scholar 

Haie, CHEN Hongyan, CHEN Hongjiao. The correlation between serum Asprosin levels and bone mineral density, balance ability fracture incidence in postmenopausal women, Chin J Osteopros, Feb 2021, 27:2.

Alobaidi MBA, Al-Samarrai RRH. Correlation between serum asprosin level and oxidative stress in Iraqi patients with type II diabetes mellitus. Sys Rev Pharm. 2020;11(12):1729–33.

CAS  Google Scholar 

Ali EA, Tahseen YH, El-Yassin HD. Thyroid Disorders and the Level of Malondialdehyde. J Fac Med Baghdad. 2009;51(1):67–70.

Google Scholar 

Bover J, Ureña-Torres P, Torregrosa J-V, Rodríguez-García M, Castro-Alonso C, Górriz JL, et al. Osteoporosis, bone mineral density and CKD–MBD complex (I): diagnostic considerations. Nefrología (English Edition). 2018;38(5):476–90.

Article  Google Scholar 

Mishra I, Duerrschmid C, Ku Z, He Y, Xie W, Silva ES, et al. Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. Elife. 2021;10: e63784.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi X, Jiang J, Hong R, Xu F, Dai S. Circulating IGFBP-3 and interleukin 6 as predictors of osteoporosis in Postmenopausal Women: a cross-sectional study. Mediat Inflamm. 2023;2023.

Seyhanli ES, Koyuncu I, Yasak IH, Demir HA, Temiz E. Asprosin and oxidative stress level in COVID-19 patients. Clin Lab. 2022;68(1).

Nori W, Zghair MAG. Omicron targets upper airways in pediatrics, elderly and unvaccinated population. World J Clin Cases. 2022;10(32):12062.

Article  PubMed  PubMed Central  Google Scholar 

Ali AI, Nori W. Correlation of serum visfatin level in non-obese women with polycystic ovary syndrome and matched control. Reprod Sci. 2022;29(11):3285–93.

Article  CAS  PubMed  Google Scholar